secwatch.observer — SEC 8-K summary
======================================

Issuer:     Genprex, Inc. (GNPX)
CIK:        0001595248
Form:       8-K
Filed at:   2024-09-26T23:59:59+00:00
Accession:  0001437749-24-030088
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Genprex receives Nasdaq deficiency notice for bid price below $1.00; 180-day cure period
--------------------------------------------------------------------------------

- Nasdaq letter dated Sept 26, 2024; stock fails minimum $1.00 bid price for 30 consecutive business days.
- Cure period ends March 25, 2025; must have $1.00 closing bid for 10 consecutive days to regain compliance.
- Company may qualify for additional 180-day period if it meets other listing standards and notifies Nasdaq.
- Potential actions include reverse stock split; delisting risk if unable to cure.
- Common stock continues trading on Nasdaq Capital Market while Company monitors bid price.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1595248/000143774924030088/0001437749-24-030088-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1595248/000143774924030088/gnpx20240920_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-030088

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer